Cargando…

Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera

Detalles Bibliográficos
Autores principales:	Tiong, I S, Casolari, D A, Nguyen, T, Van Velzen, M J M, Ambler, K, D'Andrea, R J, Ross, D M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022181/ https://www.ncbi.nlm.nih.gov/pubmed/27540717 http://dx.doi.org/10.1038/bcj.2016.70

Ejemplares similares

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
por: Mathur, Abhinav, et al.
Publicado: (2022)

Koilonychia and Polycythæmia Vera
por: Glazebrook, A. J.
Publicado: (1944)

The treatment of polycythaemia vera: an update in the JAK2 era
por: Finazzi, G., et al.
Publicado: (2007)

Unusual Neurological Symptoms in Polycythæmia Rubra Vera
por: Grunberg, A., et al.
Publicado: (1950)

Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations
por: Ibrahim, Ibrahim Khidir, et al.
Publicado: (2019)

Polycythæmia Vera with Tuberculosis Splenomegaly. Report of a Case
por: Guild, A. A., et al.
Publicado: (1950)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
por: Abdalla, ELMustafa, et al.
Publicado: (2022)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
por: Sthaneshwar, Pavai, et al.
Publicado: (2022)

The epidemiology of polycythaemia rubra vera in England and Wales 1968-1982.
por: Prochazka, A. V., et al.
Publicado: (1986)

Crescentic Glomerulonephritis Associated with Polycythaemia Vera: A Rare Occurrence
por: Dwivedi, Rohan, et al.
Publicado: (2022)

Haemoglobinopathia Ypsilanti – A rare, but important differential diagnosis to polycythaemia vera()
por: Nygaard, Marietta, et al.
Publicado: (2013)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
por: Tipgomut, Chartsiam, et al.
Publicado: (2021)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
por: Amé, Shanti, et al.
Publicado: (2023)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
por: Carpenter, Lewis, et al.
Publicado: (2022)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Okikiolu, Jumoke, et al.
Publicado: (2022)

Delayed diagnosis of polycythaemia vera in an adult female with non-cirrhotic portal hypertension
por: Tachi, Kenneth, et al.
Publicado: (2022)

Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera
por: Stuckey, Ruth, et al.
Publicado: (2021)

Polycythaemia Vera JAK 2 Mutation in a Patient with Underlying Chronic Obstructive Pulmonary Disease at a Primary Care Setting
por: Mahmud, Rafidah, et al.
Publicado: (2020)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2021)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline
por: McMullin, Mary F. F., et al.
Publicado: (2018)

Polycythaemia treated with nephrectomy
por: Thuesen, Anne Daugaard, et al.
Publicado: (2011)

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA
por: Segura Diaz, A., et al.
Publicado: (2022)

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study
por: Palandri, Francesca, et al.
Publicado: (2023)

Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?
por: Sarmento, Maria, et al.
Publicado: (2023)

Successful treatment of proton pump inhibitor induced sporadic fundic gland polyps with an argon plasma coagulator in a patient with polycythaemia vera
por: Kato, Kazuya, et al.
Publicado: (2017)

Chronic Cyanosis, with Polycythæmia and Enlarged Spleen
por: Begg, C., et al.
Publicado: (1905)

A Case of Erythræmia or Splenic Polycythæmia
por: Parker, G.
Publicado: (1920)

Coronary artery bypass grafting in a patient with polycythaemia rubra vera - a rare indication with a spectrum of complication: a case report
por: Al-Fadhli, Jamal, et al.
Publicado: (2009)

Benign familial polycythaemia in a young male
por: Somnath, Maitra, et al.
Publicado: (2012)

Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone
por: Staples, Laura, et al.
Publicado: (2017)

A Case of Congenital Heart Disease, with Extreme Secondary Polycythæmia and Orthostatic Albuminuria; Also Some Remarks on Polycythæmia in Cardiac Cases
por: Weber, F. Parkes
Publicado: (1909)

A Case of Chronic Cyanosis, with Polycythæmia and Enlarged Spleen
por: Ronaldson, R. M.
Publicado: (1904)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF)
por: Mesa, Ruben, et al.
Publicado: (2016)

JAK2 V617F and the evolving paradigm of polycythemia vera
por: Means, Robert T.
Publicado: (2010)

Bilateral renal vein thrombosis due to inapparent polycythaemia
por: Rapur, Ram, et al.
Publicado: (2011)

Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).
Publicado: (1981)

Hypoxaemia, sport and polycythaemia: a case from Imperial College London
por: Yasuda, Wakana, et al.
Publicado: (2015)

JAK2 Unmutated Polycythaemia—Real-World Data of 10 Years from a Tertiary Reference Hospital
por: Jalowiec, Katarzyna Aleksandra, et al.
Publicado: (2022)

Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
por: Martins De Oliveira Filho, Cilomar, et al.
Publicado: (2022)

JAK2(V617F) allele burden in polycythemia vera: burden of proof
por: Moliterno, Alison R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2s2g22cbr4eoiuf3et12e0566